Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Organigram Global Inc. (OGI : NSDQ)

• Company Description    Organigram Global Inc. is focused on producing cannabis for adult recreational consumers. Organigram Global Inc., formerly known as OrganiGram Holdings Inc, is based in TORONTO. Number of Employees: 914

• Price / Volume Information    Yesterday's Closing Price: $1.66 Daily Weekly Monthly 20 Day Moving Average: 742,433 shares Shares Outstanding: 134.05 (millions) Market Capitalization: $222.52 (millions) Beta: 1.49 52 Week High: $2.00 52 Week Low: $0.85 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 6.41% 4.49% 12 Week 25.76% 14.18% Year To Date 3.11% -7.94%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1400-145 King Street West - Toronto,A6 M5H 1J8 CAN ph: 855-961-9420 fax: - None http://www.organigram.ca

• General Corporate Information    Officers Beena Goldenberg - Chief Executive Officer Peter Amirault - Chairman Greg Guyatt - Chief Financial Officer Megan McCrae - Senior Vice-President Nathalie Kubrick - Senior Vice President of Operations Peer Information Organigram Global Inc. (BJCT) Organigram Global Inc. (CADMQ) Organigram Global Inc. (APNO) Organigram Global Inc. (UPDC) Organigram Global Inc. (IMTIQ) Organigram Global Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 68617J100 SIC: 2834 Fiscal Year Fiscal Year End: September Last Reported Quarter: 06/01/25 Next Expected EPS Date: 12/17/25 Share - Related Items Shares Outstanding: 134.05 Most Recent Split Date: 7.00 (0.25:1) Beta: 1.49 Market Capitalization: $222.52 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.01 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.06 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 12/17/25

• Fundamental Ratios P/E Current FY Estimate: 27.67 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.80 Price/Cash Flow: - Price / Sales: 1.39 EPS Growth vs. Year Ago Period: -250.00% vs. Previous Quarter: 40.00% Sales Growth vs. Year Ago Period: 70.49% vs. Previous Quarter: 11.98% ROE 06/30/25 - -8.19 03/31/25 - -5.93 12/31/24 - -8.59 ROA 06/30/25 - -5.79 03/31/25 - -4.39 12/31/24 - -6.54 Current Ratio 06/30/25 - 2.59 03/31/25 - 3.42 12/31/24 - 3.36 Quick Ratio 06/30/25 - 1.42 03/31/25 - 1.90 12/31/24 - 1.85 Operating Margin 06/30/25 - -12.87 03/31/25 - -10.07 12/31/24 - -15.48 Net Margin 06/30/25 - 2.86 03/31/25 - 8.05 12/31/24 - -31.69 Pre-Tax Margin 06/30/25 - -1.50 03/31/25 - 8.17 12/31/24 - -31.53 Book Value 06/30/25 - 2.08 03/31/25 - 2.15 12/31/24 - 1.83 Inventory Turnover 06/30/25 - 1.36 03/31/25 - 1.33 12/31/24 - 1.23 Debt-to-Equity 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - 10.41 03/31/25 - 8.23 12/31/24 - 9.71

Powered by Zacks Investment Research ©